Placebo Clinical Trial
Official title:
Assessment of Cost-effectiveness in Two Empirically-based Psychotherapies for Borderline Personality Disorder: A Randomized Controlled Trial
Verified date | March 2020 |
Source | Shalvata Mental Health Center |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Patients suffering from borderline personality disorder (BPD) are considered frequent utilizers of psychiatric emergency rooms and of psychiatric hospitalizations. Nonetheless, recent studies challenge the effectiveness of psychiatric hospitalizations in reducing BPD symptoms, and some have even indicated potentially harmful effects such as increasing suicide risk post-discharge. These findings highlight the importance of effective outpatient treatments for BPD patients in public psychiatric hospital settings. In this study we aim to assess the effectiveness and cost-effectiveness of two empirically-based treatments for BPD: dialectical behavior therapy (DBT) and dynamic deconstructive psychotherapy (DDP).
Status | Not yet recruiting |
Enrollment | 60 |
Est. completion date | October 22, 2024 |
Est. primary completion date | October 22, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 45 Years |
Eligibility |
Inclusion Criteria: - between 18 and 45 years old - diagnosis of BPD, - history of a suicide attempt within the prior year with presence of current suicidal ideation, - agrees to participate in psychotherapy - signed informed consent, Exclusion Criteria: - meet diagnostic criteria for schizophrenia, schizoaffective disorders, or have severe intellectual impairment. |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Shalvata Mental Health Center |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Incremental cost-effectiveness ratio (ICER) | The measure will be assessed by comparing health care use costs in ratio to improvement on the Columbia hardware rating scale. | The expected duration of treatment is about one year |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04852315 -
Acute Caffeine Ingestion on Futsal Performance
|
N/A | |
Completed |
NCT05427409 -
Ingestion of Beta-alanine Effects in Well-trained Tennis Players
|
N/A | |
Completed |
NCT05425563 -
Effects of Expectations on Negative Affect, Perceived Cognitive Effort, and Pain
|
N/A | |
Recruiting |
NCT05007561 -
Understanding How Opioids Affect the Experiential and Neural Signatures of Social Experiences
|
Early Phase 1 | |
Recruiting |
NCT03897998 -
Neural Correlates of Hypoalgesia Driven by Observation
|
Phase 2 | |
Recruiting |
NCT04851301 -
Neural Mechanisms of Immersive Virtual Reality in Chronic Pain
|
Phase 1/Phase 2 | |
Completed |
NCT04359147 -
The Role of Stress Neuromodulators in Decision Making Under Risk and Selective Attention to Threat
|
N/A | |
Recruiting |
NCT05145764 -
Suvorexant as an Adjunct to Buprenorphine in Persons Who Use Fentanyl
|
Phase 2 | |
Completed |
NCT01167478 -
Neurophysiological Reserve With Caffeine Manipulation
|
N/A | |
Completed |
NCT05337527 -
Neuromuscular Responses to Acute Beetroot Ingestion in Women Older Adults
|
N/A | |
Terminated |
NCT01656577 -
Pexacerfont for Stress-induced Food Craving
|
Phase 0 | |
Completed |
NCT04361968 -
Combining Animal-assisted Intervention and Placebo-induced Analgesia
|
N/A | |
Completed |
NCT03754062 -
Pharmacological Modulation of Belief Salience
|
Phase 1 | |
Not yet recruiting |
NCT04317157 -
Placebo Effects Investigated by Different Experimental Designs
|
N/A | |
Completed |
NCT01361633 -
The Cognitive Enhancing Effects of D-Cycloserine Among Non-Demented Elderly
|
Phase 2 | |
Completed |
NCT05209126 -
Impact of Beetroot Juice Ingestion on Female Rugby Performance
|
N/A | |
Completed |
NCT05521347 -
Caffeine Supplementation Improves the Cognitive Abilities and Shooting Performance of Trained E-sports Players
|
N/A | |
Completed |
NCT04975360 -
Delayed-release Bedtime Caffeine and Sleep Inertia Symptoms Immediately Upon Awakening
|
N/A | |
Completed |
NCT04671043 -
Caffeine Ingestion to Counter the Exercise-mediated Fall in Glycaemia in Type 1 Diabetes
|
N/A | |
Completed |
NCT01011465 -
The Biology of Resilience
|
N/A |